FEDERATED HERMES, INC. - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 207 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2020$87,000
-99.2%
1,376
-99.4%
0.00%
-100.0%
Q1 2020$10,869,000
-7.0%
212,748
+44.7%
0.03%
+23.1%
Q4 2019$11,685,000
+1466.4%
146,996
+856.7%
0.03%
+1200.0%
Q3 2019$746,000
-80.3%
15,365
-78.6%
0.00%
-77.8%
Q2 2019$3,783,000
+646.2%
71,923
+650.8%
0.01%
+800.0%
Q1 2019$507,000
+124.3%
9,580
+91.6%
0.00%0.0%
Q2 2018$226,0005,0000.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q1 2019
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders